The global contraceptive drugs market size was valued at USD 14.32 billion in 2021. It is expected to reach USD 28.96 billion by 2030, growing at a CAGR of 7.3% during the forecast period (2022–2030). For more info @ https://straitsresearch.com/report/contraceptive-drugs-market
The global contraceptive drugs market size was valued at USD 14.32 billion in 2021. It is expected to reach USD 28.96 billion by 2030, growing at a CAGR of 7.3% during the forecast period (2022–2030). For more info - https://straitsresearch.com/report/contraceptive-drugs-market
The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during the forecast period.
The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during the forecast period.
The global contraceptive drugs market size was evaluated at $14,324.12 million in 2019, and is estimated to garner $24,412.22 million by 2027, registering a CAGR of 6.9% during the forecast period.
Increasing awareness among women in developed as well as rural areas of developing countries such as India and Africa regarding HIV, STIs, fertility control and birth-control is propelling this arcade to be progressing at a CAGR of 6%-7% during the forecast period of 2019-2025.
Contraceptives Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $43,812 million by 2022, registering a CAGR of 6.4% during the period 2016-2022. Contraceptive drugs are expected to dominate the market throughout the study period. North America would continue its lead, accounting for more than one-third share of the world contraceptive market in 2015. Get PDF Sample: https://www.alliedmarketresearch.com/request-sample/451
The global women’s health market is expected to reach USD 24.48 Billion by 2027, according to a new report by Emergen Research. The women’s healthcare market is experiencing high demand attributable to a growing demand for devices (intrauterine devices, vaginal rings, and implants) and drugs (Prolia, Evista, Xgeva, Mirena, and Zometa, among others) in applications comprising contraceptives, postmenopausal osteoporosis, hormonal infertility, menopause, endometriosis, and polycystic ovary syndrome (PCOS), among others.
Global Gynecology Drugs Market by The Business Research Company is segmented as Hormonal Therapy, Non-Hormonal Therapy, Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, Others
China's demand for anti-tumor drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow and long-term forecasts through 2017 and 2022 are presented.
Despite this, the demand for PCOS treatment continues to incur a sluggish growth across the US. Persistence Market Research’s recent publication estimates that the US$ 230 Mn PCOS treatment market in the US will exhibit a moderate value CAGR of 3.9% to reach US$ 313.2 Mn by the end of 2024.
The global intrauterine contraceptive devices market is a competitive market with a number of market players. Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland) are some of the major players operating in this market. Browse full report @ http://goo.gl/StCEXP
The report on Womens Health Market by treatment type (hormonal, non-hormonal), diseases indication (hypothyroidism, osteoporosis, uterine fibroid, cancer, post-menopausal syndrome, contraceptive, urinary tract infection), distribution channel (online, hospital, retail pharmacy) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Womens Health Market is projected to grow at a CAGR of 5.72% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Contraceptive Devices Market demand rising in the upcoming years, Contraceptive devices for female are available in different types that are expected to lead
The report titled Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory) provides a comprehensive analysis of Vietnam pharmaceutical market overview and size, growth drivers and restraints.
Global gynecology drugs market size is expected to reach $54.1 Bn by 2028 at a rate of 5.4%, segmented as by therapeutics, hormonal therapy, non-hormonal therapy
... Pharmaceutical companies have to compete with latest forms of contraception Contraceptive vaccines Vaginal rings Intrauterine Contraception Cervical caps ...
Global Hormonal Contraceptives Market by The Business Research Company is segmented as Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Others https://bit.ly/2Wx1cC1
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report.
Data Bridge Market Research analyses the market to grow at a CAGR of 8.1% in the above-mentioned forecast period. https://www.databridgemarketresearch.com/reports/global-implantable-drug-delivery-market
Breast Cancer Therapeutics Market 2019 Industry Demand, Share, Global Trend, Industry News, Business Growth, Top Key Players Update, Business Statistics, and Research Methodology by Forecast to 2025
Global Polycystic Ovarian Syndrome Treatment Market by The Business Research Company is segmented Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors
The Global Female Contraception Drug Market witnessed a rapid growth in the historic period from 2016 to 2019 and is anticipated to witness significant growth during the forecast period.
Prescription and nonprescription drugs became legally distinguished from one ... in 2006, global spending on prescription drugs topped $600 billion, even as ...
Pharmaceutical contract packaging relates to outsourcing to third party suppliers of packaging operations. In this the pharma companies seeks services from the other companies for the packaging of their drugs.
The section details about the geographical details of Morocco. It also details the prevalent economic conditions of Morocco in terms of GDP per capita, GDP sources, demographic profile of the country, and political structure and environment. For More Info :- https://www.bharatbook.com/healthcare-market-research-reports-686696/healthcare-access-morocco.html
Most of today's major pharmaceutical companies were founded in the late 19th and ... A molecular weight under 500 daltons. An octanol-water partition ...
... trademark, trade name or other identification mark or imprint or any likeness ... Dummy contraceptive pills & false anticancer drugs in Brazil (1998) ...
According to the latest research report by IMARC Group, The United States premenstrual syndrome treatment market size is projected to exhibit a growth rate (CAGR) of 3.90% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-premenstrual-syndrome-treatment-market
The Business Research Company offers polycystic ovarian syndrome treatment market research report 2023 with industry size, share, segments and market growth